title: The innate immune system recognizes and regulates major histocompatibility complex class I (MHCI) expression on MHCIlow tumor cells.
abstract: Tumor cells and the immune system play a lethal "pas de deux" during tumor development. However, it is not clear which role the innate immune system plays in these interactions. We studied the interaction of normal spleen cells (NSCs) with tumor cells expressing low levels of MHCI on the cell surface. This interaction induces increased MHCI expression on the MHCI(low) tumor cells by a cell-cell contact-dependent, IFN-gamma-mediated mechanism. The effector cells responsible for the increased IFN-gamma production were identified as CD4+ CD1d-independent NKT cells, NK1.1+ NK cells and CD4+ CD11c+ DCs. The possible three cell collaboration is not activated by MHCI(high) tumor cells or normal fibroblasts. Kinetic experiments showed that the increase in IFN-gamma production induced by MHCI(low) tumor cells happens in two consecutive waves, an early peak around 12 hours, followed by a second more important peak around day 2-3. Thus, we propose that CD4+ CD1d-independent NKT cells are activated by the MHCI(low) tumor cells, they release IFN-gamma stimulating DCs to produce IL-12, which in turn activates NK cells to produce large amounts of IFN-gamma. The recognition mechanism used by the CD4+ CD1d-independent non-classical NKT cells is unknown. Monoclonal antibody (mAb) blocking experiments using antibodies against either activating or inhibitory receptors or co-receptors on NKT/NK cells gave no conclusive results. Moreover, NSCs from either normal or MHCII(-/-) mice augmented MHCI expression on MHCI(low) tumors, excluding a significant role of CD4-MHCII interactions in the system. Hence the initial recognition mechanism in this system still awaits further experimentation.
authors.affiliation: Institut de Sciences et Technologies du Médicament de Toulouse, UMR-2587, CNRS-Pierre Fabre, Toulouse, France. bent.rubin@istmt.cnrs.fr <bent.rubin@istmt.cnrs.fr>
authors.forename: Bent
authors.initials: B
authors.lastname: Rubin
authors.forename: Joëlle
authors.initials: J
authors.lastname: Riond
authors.forename: Laetitia
authors.initials: L
authors.lastname: Courtiade
authors.forename: Nicolas
authors.initials: N
authors.lastname: Roullet
authors.forename: Jean-Edouard
authors.initials: JE
authors.lastname: Gairin
mesh_terms: D000818:Animals; D018949:Antigens, CD1 / Q000276:immunology; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D002450:Cell Communication; D045744:Cell Line, Tumor; D003713:Dendritic Cells / Q000276:immunology; D015395:Histocompatibility Antigens Class I / Q000276:immunology*; D007113:Immunity, Innate / Q000276:immunology*; D007694:Killer Cells, Natural / Q000276:immunology; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D009369:Neoplasms / Q000276:immunology*; D013154:Spleen / Q000276:immunology
chemical_list: D018949:Antigens, CD1; D015395:Histocompatibility Antigens Class I
references.citation: J Exp Med. 2003 Jul 7;198(1):173-81
references.pmid: 12847141
references.citation: J Immunol. 1998 Jul 15;161(2):897-908
references.pmid: 9670968
references.citation: J Immunol. 1987 Jun 15;138(12):4539-44
references.pmid: 3584981
references.citation: J Immunol. 2000 Feb 15;164(4):1741-5
references.pmid: 10657619
references.citation: Nat Immunol. 2003 Dec;4(12):1164-5
references.pmid: 14639465
references.citation: Cancer Res. 2003 Jul 15;63(14):4095-100
references.pmid: 12874012
references.citation: Nat Immunol. 2001 Jul;2(7):585-9
references.pmid: 11429541
references.citation: Nat Rev Immunol. 2001 Oct;1(1):41-9
references.pmid: 11905813
references.citation: Immunity. 2000 Feb;12(2):211-21
references.pmid: 10714687
references.citation: Eur J Immunol. 2004 Oct;34(10):2635-41
references.pmid: 15368278
references.citation: Cancer Res. 2001 Feb 1;61(3):1095-9
references.pmid: 11221838
references.citation: Expert Opin Biol Ther. 2005 Apr;5(4):565-75
references.pmid: 15934834
references.citation: Immunology. 2002 Jan;105(1):92-100
references.pmid: 11849319
references.citation: J Immunol. 1988 Mar 15;140(6):2096-102
references.pmid: 3126240
references.citation: J Exp Med. 2005 Nov 7;202(9):1279-88
references.pmid: 16275765
references.citation: J Exp Med. 2003 Aug 4;198(3):433-42
references.pmid: 12900519
references.citation: J Immunol. 2001 Mar 15;166(6):3890-9
references.pmid: 11238633
references.citation: J Immunol. 1999 Jun 1;162(11):6410-9
references.pmid: 10352254
references.citation: Immunol Rev. 2001 Jun;181:104-14
references.pmid: 11513132
references.citation: Nat Immunol. 2000 Aug;1(2):119-26
references.pmid: 11248803
references.citation: Cancer Immunol Immunother. 2007 Feb;56(2):227-36
references.pmid: 16783578
references.citation: Immunity. 2007 Oct;27(4):572-84
references.pmid: 17950006
references.citation: J Immunol. 1986 Jun 15;136(12):4729-34
references.pmid: 3711664
references.citation: Nature. 1986 Feb 20-26;319(6055):675-8
references.pmid: 3951539
references.citation: J Biol Chem. 1982 Sep 25;257(18):10766-9
references.pmid: 6955305
references.citation: J Immunol. 2004 Dec 1;173(11):7062-9
references.pmid: 15557204
references.citation: J Immunol. 2002 Nov 15;169(10):5522-30
references.pmid: 12421928
references.citation: Eur J Immunol. 1993 Jun;23(6):1201-14
references.pmid: 8500519
references.citation: J Immunol. 2008 Jun 15;180(12):8159-67
references.pmid: 18523281
references.citation: Nat Rev Cancer. 2002 Jun;2(6):409-19
references.pmid: 12189383
references.citation: Cell Immunol. 1990 Mar;126(1):196-210
references.pmid: 2137376
references.citation: Eur J Immunol. 1988 Jan;18(1):97-104
references.pmid: 2831066
references.citation: J Immunol. 2003 May 1;170(9):4427-31
references.pmid: 12707316
references.citation: J Immunol. 1999 Nov 1;163(9):4647-50
references.pmid: 10528160
references.citation: J Immunol. 1998 Sep 1;161(5):2187-94
references.pmid: 9725210
references.citation: Nat Rev Immunol. 2004 Mar;4(3):231-7
references.pmid: 15039760
references.citation: Blood. 2000 Oct 1;96(7):2511-9
references.pmid: 11001905
references.citation: Nat Med. 2006 Feb;12(2):214-9
references.pmid: 16444265
references.citation: J Immunol. 2001 Jan 15;166(2):1097-105
references.pmid: 11145690
references.citation: J Exp Med. 1985 Dec 1;162(6):1745-59
references.pmid: 3877776
references.citation: Annu Rev Immunol. 1988;6:359-80
references.pmid: 3289570
references.citation: Scand J Immunol. 2009 Mar;69(3):275-90
references.pmid: 19281540
references.citation: Annu Rev Immunol. 2004;22:329-60
references.pmid: 15032581
references.citation: Proc Natl Acad Sci U S A. 1985 Apr;82(8):2427-31
references.pmid: 2581247
references.citation: Annu Rev Immunol. 1993;11:571-611
references.pmid: 8476573
references.citation: Nat Rev Immunol. 2004 Mar;4(3):190-8
references.pmid: 15039756
references.citation: Nat Med. 2001 May;7(5):625-9
references.pmid: 11329066
references.citation: Immunity. 2003 Oct;19(4):561-9
references.pmid: 14563320
references.citation: J Immunol. 2008 Apr 15;180(8):5167-71
references.pmid: 18390697
references.citation: Proc Natl Acad Sci U S A. 2003 May 27;100(11):6682-7
references.pmid: 12724523
references.citation: Nat Immunol. 2005 Mar;6(3):239-45
references.pmid: 15716973